Cost-effectiveness analysis of responsive neurostimulation for drug-resistant focal onset epilepsy. Youngerman BE, Mahajan UV, Dyster TG, Srinivasan S, et al. Epilepsia 2021 Aug 29. doi: 10.1111/epi.17049.

Read + Share

Amedeo Smart

Independent Medical Education

Youngerman BE, Mahajan UV, Dyster TG, Srinivasan S, et al. Cost-effectiveness analysis of responsive neurostimulation for drug-resistant focal onset epilepsy. Epilepsia 2021 Aug 29. doi: 10.1111/epi.17049.
PMID: 34458986